The treatment combines SciSparc’s Palmitoylethanolamide (PEA), the active pharmaceutical ingredient of its proprietary CannAmide™, and…
Export of LaNeo MDMA Completes August 2022 Contract Fulfillment VANCOUVER, British Columbia, June 16, 2023…
Export of LaNeo MDMA Completes August 2022 Contract Fulfillment VANCOUVER, British Columbia, June 16, 2023…
Hypoimmune (HIP)-modified CD19-directed CAR T cells have the potential to serve as a universal off-the-shelf…
Hypoimmune (HIP)-modified CD19-directed CAR T cells have the potential to serve as a universal off-the-shelf…
PALO ALTO, Calif., June 16, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
PALO ALTO, Calif., June 16, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
MINNEAPOLIS, June 16, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive…
MINNEAPOLIS, June 16, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive…
vTv discovered small molecule RAGE inhibitor is being developed by Cantex under worldwide development and…
vTv discovered small molecule RAGE inhibitor is being developed by Cantex under worldwide development and…
SALT LAKE CITY, June 16, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN), along with…
SALT LAKE CITY, June 16, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN), along with…
SAN DIEGO, June 16, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
SAN DIEGO, June 16, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime…
Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime…
GAITHERSBURG, Md., June 16, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
GAITHERSBURG, Md., June 16, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
Company Greatly Enhances Its Solutions Portfolio for Larger Networks with More Fiber Optics FREMONT, Calif.,…